Compare SD & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SD | QTRX |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Laboratory Analytical Instruments |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.9M | 352.7M |
| IPO Year | 2007 | 2017 |
| Metric | SD | QTRX |
|---|---|---|
| Price | $14.31 | $6.46 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $11.33 |
| AVG Volume (30 Days) | 320.9K | ★ 654.8K |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | ★ 3.35% | N/A |
| EPS Growth | ★ 40.92 | N/A |
| EPS | ★ 1.79 | N/A |
| Revenue | ★ $155,930,000.00 | $130,203,000.00 |
| Revenue This Year | $31.95 | N/A |
| Revenue Next Year | $16.82 | $28.28 |
| P/E Ratio | $7.99 | ★ N/A |
| Revenue Growth | ★ 29.68 | N/A |
| 52 Week Low | $8.81 | $4.05 |
| 52 Week High | $15.56 | $12.41 |
| Indicator | SD | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.14 | 42.84 |
| Support Level | $14.23 | $6.52 |
| Resistance Level | $14.68 | $7.10 |
| Average True Range (ATR) | 0.34 | 0.36 |
| MACD | -0.11 | -0.17 |
| Stochastic Oscillator | 32.60 | 5.64 |
SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services. Its primary areas of operation are the Mid-Continent in Oklahoma and Kansas.
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.